book lift ep target price
healthi cro fundament intact follow recent discuss
recent industri commentari indic acceler rfp volum
healthi biotech fund backdrop qtd ytd accord
bioworld maintain ep ep move
reflect continu momentum revenu book
trend boost tp higher view
greater convict iclr long term prospect continu market share
gain evid recent quarterli report strong balanc sheet
increment capit deploy opportun also supplement growth
step activ nt iclr complet one acquisit
past month mapi top prioriti like near
term horizon net cash posit million robust deal
pipelin manag recent note could complet two deal year
end potenti area interest includ continu invest late stage/
pharmacovigil site network potenti europ apac china
japan central laboratori expans current revenu
target like bolt-on transact million
rule larger deal note iclr previous note bidder
parexel ultim sold privat equiti billion
reiter outperform forecast ep includ
top-line growth cc excl net btb
continu recent strong trend note gross margin pressur
continu balanc hire ramp ahead futur growth
dynam off-set on-going sg leverag
ep iclr trade premium cro peer view
greater upsid warrant heighten convict sustain
impress top-line strength excl capit
deploy opportun risk includ shift demand cancel
valuat metric
number share
price month
 close
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
icon public limit compani icon ireland-bas contract
servic pharmaceut biotechnolog medic devic
price jun rate outperform target price analyst erin wright
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
 close
blue sky valuat iclr assum substanti
new busi win addit project award offset
sizabl cancel increment profit margin expans
pronounc strength spend outsourc demand
grey sky valuat iclr assum greater-
than-expect declin busi largest custom
consolid capit deploy misstep weaken demand
outsourc
compani mention price
